Mark J. Kwakkenbos

2.1k citations

22 papers · 1.4k indexed · h-index 18

Molecular Biology
Immunology top 5%
Radiology, Nuclear Medicine and Imaging top 5%
Oncology top 10%
Epidemiology

Co-authors: Jörg Hamann Siamon Gordon Martin Stacey Hsi‐Hsien Lin Hergen Spits Tim Beaumont Etsuko Yasuda Gin-Wen Chang
Topics: T-cell and B-cell Immunology (8 papers)Immune Cell Function and Interaction (7 papers)Glycosylation and Glycoproteins Research (5 papers)
Cited by: Immunology and Allergy Immunology Radiology, Nuclear Medicine and Imaging
Journals: Proceedings of the National Academy of Sciences Nature Medicine The Journal of Experimental Medicine
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Mark J. Kwakkenbos

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark J. Kwakkenbos

Since Specialization

Citations

This map shows the geographic impact of Mark J. Kwakkenbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Kwakkenbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Kwakkenbos more than expected).

Fields of papers citing papers by Mark J. Kwakkenbos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Kwakkenbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Kwakkenbos. The network helps show where Mark J. Kwakkenbos may publish in the future.

Co-authorship network of co-authors of Mark J. Kwakkenbos

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Kwakkenbos. A scholar is included among the top collaborators of Mark J. Kwakkenbos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Kwakkenbos. Mark J. Kwakkenbos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus 2019 ·Frontiers in Immunology ·David Goldeck,(unknown),(unknown),(unknown),(unknown),P. Roychoudhury,(unknown),Katy Moffat,Arjen Q. Bakker,Mark J. Kwakkenbos,Jean‐Pierre Frossard,Raymond R. R. Rowland,Michael P. Murtaugh,Simon P. Graham	6
2	De novo gene mutations in normal human memory B cells 2018 ·Leukemia ·Linda M. Slot,Thera A.M. Wormhoudt,Mark J. Kwakkenbos,Koen Wagner,Aranka Ballering,Aldo Jongejan,(unknown),Jeroen E. J. Guikema,Richard J. Bende,C. J. M. van Noesel	4
3	Generation and Characterization of Anti–Citrullinated Protein Antibody–Producing B Cell Clones From Rheumatoid Arthritis Patients 2018 ·Arthritis & Rheumatology ·Kristine Germar,Cynthia M. Fehres,Hans Ulrich Scherer,N. van Uden,(unknown),Nataliya Yeremenko,Monika Hansson,Priscilla F. Kerkman,Ellen I. H. van der Voort,Evan Reed,(unknown),Mark J. Kwakkenbos,Arjen Q. Bakker,Lars Klareskog,Vivianne Malmström,Niek de Vries,René E. M. Toes,Karin Lundberg,Hergen Spits,Dominique Baeten	21
4	Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure 2017 ·Molecular Immunology ·Anna M. Gram,(unknown),(unknown),(unknown),(unknown),Mark J. Kwakkenbos,Rob C. Hoeben,Søren R. Paludan,Maaike E. Ressing	33
5	Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP 2017 ·Scientific Reports ·Joanne M. Donkers,(unknown),Gerard J. P. van Westen,Mark J. Kwakkenbos,Adriaan P. IJzerman,Ronald P.J. Oude Elferink,Ulrich Beuers,Stephan Urban,Stan F.J. van de Graaf	73
6	Stable long‐term cultures of self‐renewing B cells and their applications 2016 ·Immunological Reviews ·Mark J. Kwakkenbos,Pauline M. van Helden,Tim Beaumont,Hergen Spits	33
7	Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity 2014 ·Proceedings of the National Academy of Sciences ·Koen Wagner,Mark J. Kwakkenbos,(unknown),(unknown),Martino Böhne,Koenraad F. van der Sluijs,Martin D. Witte,(unknown),Lisette A. H. M. Cornelissen,Tim Beaumont,Arjen Q. Bakker,Hidde L. Ploegh,Hergen Spits	67
8	Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire 2013 ·Methods ·Mark J. Kwakkenbos,Arjen Q. Bakker,Pauline M. van Helden,Koen Wagner,Etsuko Yasuda,Hergen Spits,Tim Beaumont	17
9	Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming 2009 ·Nature Medicine ·Mark J. Kwakkenbos,Sean A. Diehl,Etsuko Yasuda,Arjen Q. Bakker,Caroline M. M. van Geelen,Michaël V. Lukens,Grada M. van Bleek,Myra N. Widjojoatmodjo,Willy Bogers,Henrik E. Mei,Andreas Radbruch,Ferenc A. Scheeren,Hergen Spits,Tim Beaumont	220
10	Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization 2008 ·Haematologica ·Melissa van Pel,(unknown),Mark J. Kwakkenbos,Jörg Hamann,Willem E. Fibbe	21
11	STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation 2008 ·The Journal of Immunology ·Sean A. Diehl,Heike Schmidlin,Maho Nagasawa,Simon D. van Haren,Mark J. Kwakkenbos,Etsuko Yasuda,Tim Beaumont,Ferenc A. Scheeren,Hergen Spits	178
12	EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor 2007 ·European Journal of Immunology ·Jörg Hamann,Nathalie Koning,Walter Pouwels,Laurien H. Ulfman,Marco van Eijk,Martin Stacey,Hsi‐Hsien Lin,Siamon Gordon,Mark J. Kwakkenbos	108
13	CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40 2006 ·The Journal of Experimental Medicine ·Megan K. L. MacLeod,Mark J. Kwakkenbos,Alison Crawford,Sheila Brown,Brigitta Stockinger,Koen Schepers,Ton N. Schumacher,David Gray	40
14	An unusual mode of concerted evolution of the EGF‐TM7 receptor chimera EMR2 2006 ·The FASEB Journal ·Mark J. Kwakkenbos,Mourad Matmati,Ole Madsen,Walter Pouwels,Yongyi Wang,Ronald E. Bontrop,Peter J. Heidt,Robert M. Hoek,Jörg Hamann	39
15	Identification of the epidermal growth factor–TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue 2005 ·Arthritis & Rheumatism ·(unknown),Mark J. Kwakkenbos,Gwendoline J.D. Teske,Maarten C. Kraan,Tom Smeets,Martin Stacey,Hsi‐Hsien Lin,Paul P. Tak,Jörg Hamann	45
16	The EGF-TM7 family: a postgenomic view 2004 ·Immunogenetics ·Siamon Gordon,Hsi‐Hsien Lin,Jörg Hamann,Mark J. Kwakkenbos,(unknown),Martin Stacey,Mourad Matmati	105
17	Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells 2004 ·Journal of Leukocyte Biology ·Mark J. Kwakkenbos,Walter Pouwels,Mourad Matmati,Martin Stacey,Hsi‐Hsien Lin,Siamon Gordon,René A. W. van Lier,Jörg Hamann	72
18	Proteolytic cleavage of the EMR2 receptor requires both the extracellular stalk and the GPS motif 2003 ·FEBS Letters ·Gin-Wen Chang,Martin Stacey,Mark J. Kwakkenbos,Jörg Hamann,Siamon Gordon,Hsi‐Hsien Lin	56
19	Inactivation of the EGF‐TM7 receptor EMR4 after the Pan‐Homo divergence 2003 ·European Journal of Immunology ·Jörg Hamann,Mark J. Kwakkenbos,Esther C. de Jong,(unknown),Anne S. Olsen,René A. W. van Lier	36
20	The epidermal growth factor–like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans 2003 ·Blood ·Martin Stacey,Gin-Wen Chang,John Q. Davies,Mark J. Kwakkenbos,Ralph D. Sanderson,Jörg Hamann,Siamon Gordon,Hsi‐Hsien Lin	177

About Mark J. Kwakkenbos

Mark J. Kwakkenbos is a scholar working on Immunology and Allergy, Immunology and Oncology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Immunology and Allergy (183 citations), Immunology (568 citations) and Radiology, Nuclear Medicine and Imaging (259 citations). Mark J. Kwakkenbos has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jörg Hamann, Siamon Gordon, Martin Stacey, Hsi‐Hsien Lin, Hergen Spits, Tim Beaumont, Etsuko Yasuda, Gin-Wen Chang, Ferenc A. Scheeren and Sean A. Diehl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact